A research team led by MedUni Vienna has shown in a study that purely optical measurements of the viscosity of blood plasma may provide information about the severity and progression of COVID-19.
Bispecific Antibodies in Relapsed/Refractory DLBCL
Follow-up data from the EPCORE NHL-1 trial lend further support to the efficacy and safety of single-agent epcoritamab (Epkinly) in the treatment of relapsed/refractory diffuse